Coupling Activators in Oligonucleotide Synthesis: Reading the DCI Evidence Carefully

Key takeaways

Why the study looked beyond tetrazole

The authors described 1H-tetrazole as the accepted standard for deoxynucleoside phosphoramidites. Their question was narrower: whether a less acidic but more nucleophilic system could improve activation for hindered and 2′-modified monomers without simply increasing acidity and detritylation risk. Results for those substrates should not be generalized to every DNA monomer.

What the DCI experiments actually showed

In near-stoichiometric phosphorus-31 NMR experiments using 0.01 mmol phosphoramidite, 0.011 mmol alcohol and 0.08 mmol activator in deuterated acetonitrile, DCI shortened the reported activation/coupling time by about a factor of two across a defined set of modified monomers. The paper also reported a 34-mer at the printed 1 mmol scale with 1.0 M DCI, two equivalents per addition and 54% isolated yield; those conditions do not establish general platform performance.

The buffered tetrazole experiments add an important warning

N-methylimidazole with tetrazole improved coupling at one tested concentration, while more N-methylimidazole reduced yield. The authors also reported a larger-column separation limitation for that mixed formulation. The limitation belongs to the N-methylimidazole/tetrazole system and should not be transferred to DCI.

Reagent purity was reported as a process variable

The authors reported contaminant peaks when technical-grade DCI was used, but did not identify the impurity or define a numerical purity threshold in the retained article. The paper supports only the limited conclusion that reagent purity mattered in that experimental program; it cannot define a modern release specification.

What this paper does not answer

The historical sources do not compare every activator, establish current commercial grades, define safety or handling requirements, or demonstrate performance in modern therapeutic manufacturing. The paper also contains inconsistent printed units for some scales and support loadings, so those values should not be silently corrected or used as benchmarks.

A practical comparison needs a defined test matrix

Define monomer class and protecting groups, activator formulation and concentration, phosphoramidite equivalents, coupling time, scale and reactor format before comparing crude profiles or isolated yields. Historical results can identify variables to test, but they cannot replace a current experiment on the intended sequence and platform.